Reevaluation of the Treatment of Shock Secondary to Cardiac Infarction

Eliot Corday M.D., F.C.C.P. , John K. Vyden M.B.B.S. , Tzu-Wang Lang M.D. , Erno Boszormenyi M.D. , Marciano Carvalho M.D. , Herbert Gold M.D., F.C.C.P. , Alfred Goldman M.D., F.C.C.P. , Eduardo Rosselot M.D.
{"title":"Reevaluation of the Treatment of Shock Secondary to Cardiac Infarction","authors":"Eliot Corday M.D., F.C.C.P. ,&nbsp;John K. Vyden M.B.B.S. ,&nbsp;Tzu-Wang Lang M.D. ,&nbsp;Erno Boszormenyi M.D. ,&nbsp;Marciano Carvalho M.D. ,&nbsp;Herbert Gold M.D., F.C.C.P. ,&nbsp;Alfred Goldman M.D., F.C.C.P. ,&nbsp;Eduardo Rosselot M.D.","doi":"10.1378/chest.56.3.200","DOIUrl":null,"url":null,"abstract":"<div><p>When given early vasopressor<span> drugs can be an effective from of therapy for cardiogenic shock because they increase coronary blood flow, cardiac output and blood pressure. They vasodilate the coronary vascular bed and in 40 percent of the experiments, reduce total peripheral vascular resistance. The use of 3-hydroxytyramine and the vasopressor-vasodilator combination provide most effective coronary and regional perfusion to other vital organs. New mechanical circulatory assistance techniques applied to the treatment of irreversible cardiogenic shock promise that the high mortality rate associated with this dreaded complication will be reduced.</span></p></div>","PeriodicalId":11305,"journal":{"name":"Diseases of the chest","volume":"56 3","pages":"Pages 200-209"},"PeriodicalIF":0.0000,"publicationDate":"1969-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1378/chest.56.3.200","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diseases of the chest","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0096021715345453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

When given early vasopressor drugs can be an effective from of therapy for cardiogenic shock because they increase coronary blood flow, cardiac output and blood pressure. They vasodilate the coronary vascular bed and in 40 percent of the experiments, reduce total peripheral vascular resistance. The use of 3-hydroxytyramine and the vasopressor-vasodilator combination provide most effective coronary and regional perfusion to other vital organs. New mechanical circulatory assistance techniques applied to the treatment of irreversible cardiogenic shock promise that the high mortality rate associated with this dreaded complication will be reduced.

心肌梗死继发性休克治疗的再评价
早期使用血管加压药物可以有效治疗心源性休克,因为它们可以增加冠状动脉血流量、心输出量和血压。它们使冠状动脉血管床扩张,在40%的实验中,降低了周围血管的总阻力。3-羟酪胺和血管加压-血管扩张剂联合使用可为其他重要器官提供最有效的冠状动脉和局部灌注。应用于治疗不可逆心源性休克的新机械循环辅助技术有望降低与这种可怕并发症相关的高死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信